Accendra Health, Inc. (ACH)

Market Cap	230.84M -66.0%
Revenue (ttm)	2.76B +3.1%
Net Income	-1.10B
EPS	-14.32
Shares Out	76.44M
PE Ratio	n/a
Forward PE	4.36
Dividend	n/a
Ex-Dividend Date	n/a

Volume	571,657
Open	2.820
Previous Close	2.810
Day's Range	2.820 - 3.009
52-Week Range	1.840 - 9.550
Beta	1.26
Analysts	Buy
Price Target	3.38 (+11.92%)
Earnings Date	May 7, 2026

About ACH

Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home medical equipment, patient care product lines includi...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1882
• Employees: 6,500
• Stock Exchange: NYSE
• Ticker Symbol: ACH
• Website: https://www.accendrahealth.com

Financial Performance

In 2025, Accendra Health's revenue was $2.76 billion, an increase of 3.06% compared to the previous year's $2.68 billion. Losses were -$1.10 billion, 203.5% more than in 2024.

Analyst Summary

According to 2 analysts, the average rating for ACH stock is "Buy." The 12-month stock price target is $3.38, which is an increase of 11.92% from the latest price.

Price Target

$3.38

(11.92% upside)

Analyst Consensus: Buy